Status:
COMPLETED
Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborating Sponsors:
University of South Florida
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to find out if complementary and alternative medicines (CAM) should be included with traditional therapy for women with ovarian cancer. Some of the alternative medicines i...
Detailed Description
The study will be offered to women with ovarian cancer who are receiving care at the Gynecologic Oncology Clinic at H. Lee Moffitt Cancer Center. Prospective candidates, identified via chart review, w...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- A diagnosis of ovarian cancer
- An Eastern Cooperative Oncology Group (ECOG) score of 2 or less with a life expectancy of at least 12 months
- A patient being treated by a gynecologic oncologist in the Center for Women's Oncology
- Ability to read, understand, and sign the informed consent form
- Ability to read, write and understand English, which will be the language used in the materials and oral presentations
- Willingness to complete pre-test and post-test questionnaires
- Willingness to complete brief questionnaires at each session
- Willingness to participate in one follow-up telephone interview at 8 weeks after the final session
- Willingness to participate in four sessions that take place at Moffitt Cancer Center
- Access to transportation, with the ability to travel to and from Moffitt to participate in the sessions
Exclusion
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01419210
Start Date
January 1 2010
End Date
September 1 2015
Last Update
September 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States, 33612